Skip to content

LEVEUGLE

Active
Private limited companyfounded 2011active for 15 yearsBiezestraat 11, 9850 Deinze, BelgiumKBO/BCE: BE 0833.556.434
Summary

LEVEUGLE has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €67,304 and a net result of €29,582. Equity is shrinking by about 7.6% per year across the filed financial years. Its solvency ranks better than 40% of 22,382 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€297,608total assets 2025
Equity
€67,304
Profit
€29,582
Turnover not published (micro format)
Financial health
84 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Accounts 146 days early0 of 4 deeds read
Why 84raises riskSector: Retail trade (NACE 47)Equity €67,304 (22.6% of total assets)lowers riskFounded in 2011Size: total assets €297,608Show the evidence

Checked score

Score 2025
84 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 43% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Average
Solvency 48-8
equity 22.6% of total assets
Liquidity 48-4
short-term debt 27.2% · cash 7.1%
Profitability 81+4
return on assets 9.9%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,224 companies, NACE 47, micro)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024 01-2025: 0.3%● unchanged vs 12-2024lowest value 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025 08-2025: 0.3%● unchanged vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.4%▲ +0.1 percentage points vs 12-2025highest value 02-2026: 0.4%● unchanged vs 01-2026highest value 03-2026: 0.4%● unchanged vs 02-2026highest value 04-2026: 0.4%● unchanged vs 03-2026highest value 05-2026: 0.4%● unchanged vs 04-2026highest value 06-2026: 0.3%▼ -0.1 percentage points vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.72, compared with 2.42 in 2024, above the usual 1.5; short-term debt: 27.2% and cash: 7.1% of total assets), but 77.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 38% on solvency, 48% on liquidity, 73% on profitability and 14% on growth.

The bankruptcy probability was computed on 18-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Founded in 2011
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Size: total assets €297,608
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Equity €67,304 (22.6% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 05-12-2025, 146 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
146 days early
2024
134 days early
2023
130 days early
2022
135 days early
2021
40 days early
2020
130 days early
2019
132 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 121 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 17 December (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end19-10-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2019 to 2025net €29,582 ▲34.2%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €29,582 7 years View
  • Total assets 20256 financial years filed €297,608 View

By topic

Financials

Financial year
2025
Total assets
€297,608
Profit
€29,582
Solvency
22.6%
Total assets▼ 10.9%
Net result
20192025
Go to Financials

Timeline

Events
17
Since
2012
Next accounts
by 30-04-2027
  1. 30-09-2024Equity above €100,000
  2. 22-12-2023Annual accounts filed
  3. 16-12-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
08-02-2011
Year ends
30-09
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.